|
|
|
|
|
|
|
Poster: 202
Visits: 113
Title: Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP vs R-CHOP in the phase 3 LYM-3002 study
Authors: Gregor Verhoef , Tadeusz Robak, Huiqiang Huang, Olga Samoilova, Halyna Pylypenko, Noppadol Siritanaratkul, Juliana Pereira, Johannes Drach, Jiri Mayer, Rumiko Okamoto, Lixia Pei, Brendan Rooney, Helgi van de Velde, Franco Cavalli
Centre: University Hospital Leuven
|
|
You must be registered to reply or comment.
|
|
ASSOCIATION BETWEEN QUALITY OF RESPONSE AND OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA RECEIVING VR-CAP VS R-CHOP IN THE PHASE 3 LYM-3002 STUDY
|
|
You must be registered to reply or comment. |
|
|
|
|
|
|
Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
Poster most viewed in this topic |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|